154 related articles for article (PubMed ID: 37725907)
21. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
[TBL] [Abstract][Full Text] [Related]
22. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
23. CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study.
Corso G; Tagliaferri V; Massari G; Cioffi A; Rossi EMC; Veronesi P; Magnoni F
Fam Cancer; 2023 Apr; 22(2):187-192. PubMed ID: 35882702
[TBL] [Abstract][Full Text] [Related]
24. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
25. Investigation on the Role of PALB2 Gene in CDH1-Negative Patients With Hereditary Diffuse Gastric Cancer.
Carreño M; Pena-Couso L; Mercadillo F; Perea J; Urioste M
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00280. PubMed ID: 33512806
[TBL] [Abstract][Full Text] [Related]
26. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
27. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
28. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
30. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
[TBL] [Abstract][Full Text] [Related]
31. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
32. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
[TBL] [Abstract][Full Text] [Related]
33. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
34. Frequency of
Guerra J; Pinto C; Pinto P; Pinheiro M; Santos C; Peixoto A; Escudeiro C; Barbosa A; Porto M; Francisco I; Lopes P; Isidoro AR; Cunha AL; Albuquerque C; Claro I; Oliveira C; Silva J; Teixeira MR
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686589
[TBL] [Abstract][Full Text] [Related]
35.
Selvanathan A; Nixon CY; Zhu Y; Scietti L; Forneris F; Uribe LMM; Lidral AC; Jezewski PA; Mulliken JB; Murray JC; Buckley MF; Cox TC; Roscioli T
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32260281
[TBL] [Abstract][Full Text] [Related]
36. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
van der Post RS; Vogelaar IP; Carneiro F; Guilford P; Huntsman D; Hoogerbrugge N; Caldas C; Schreiber KE; Hardwick RH; Ausems MG; Bardram L; Benusiglio PR; Bisseling TM; Blair V; Bleiker E; Boussioutas A; Cats A; Coit D; DeGregorio L; Figueiredo J; Ford JM; Heijkoop E; Hermens R; Humar B; Kaurah P; Keller G; Lai J; Ligtenberg MJ; O'Donovan M; Oliveira C; Pinheiro H; Ragunath K; Rasenberg E; Richardson S; Roviello F; Schackert H; Seruca R; Taylor A; Ter Huurne A; Tischkowitz M; Joe ST; van Dijck B; van Grieken NC; van Hillegersberg R; van Sandick JW; Vehof R; van Krieken JH; Fitzgerald RC
J Med Genet; 2015 Jun; 52(6):361-74. PubMed ID: 25979631
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
[TBL] [Abstract][Full Text] [Related]
38. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
Graziano F; Humar B; Guilford P
Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
[TBL] [Abstract][Full Text] [Related]
39. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin germline mutation carriers: clinical management and genetic implications.
Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
